Many findings support a possible involvement of a subgroup of human papillomaviruses (HPVs), called cutaneous beta HPV types, in the development of non-melanoma skin cancer. The skin of transgenic (Tg) mice expressing viral oncoproteins E6 and E7 from different cutaneous beta HPV types, including HPV38, showed an increased susceptibility to UV-induced and/or chemically induced skin carcinogenesis compared with wild-type animals. In this study, we show that beta HPV38 E6 and E7 oncoproteins act as promoter and progression factors in multi-stage skin carcinogenesis, strongly cooperating with the initiator and DNA damage agent 7,12-dimethylbenz[a]anthracene. In contrast, exposure of HPV38 E6/E7 Tg mice to the promoter 12-Otetradecanoylphorbol-13-acetate did not significantly result in the development of skin lesions. These findings further support the role of beta HPV types in skin carcinogenesis, providing additional insight into their precise contribution to the multi-step process.
Biological and epidemiological data suggest that a subgroup of cutaneous human papillomavirus (HPV) types that belong to the genus beta are involved in the development of non-melanoma skin cancer (NMSC) (Pfister, 2003; Bouvard et al., 2006) . Beta HPV types were initially isolated from patients with a rare autosomal recessive genetic disorder called epidermodysplasia verruciformis who have an increased susceptibility to beta HPV infection and NMSC development. However, it is now clear that beta HPV types are also widely and abundantly present in the skin of normal individuals (Bouvard et al., 2006; Pfister, 2003) . Similar to the high-risk mucosal HPV types, the products of the two early E6 and E7 genes from beta HPVs display transforming properties in several in vitro experimental models, including the natural host cells, primary human keratinocytes (Accardi et al., 2006; Caldeira et al., 2003; Gabet et al., 2008; Howie et al., 2011; Muench et al., 2010; Muschik et al., 2011; Wallace et al., 2012) . In addition, several transgenic (Tg) mouse models were developed that highlighted the transforming properties of E6 and E7 from certain beta HPV types (Dong et al., 2005; Michel et al., 2006; Schaper et al., 2005) . We previously generated a Tg mouse model with ectopic beta HPV38 E6 and E7 expression in the undifferentiated basal layer of epithelia under the control of the keratin 14 (K14) promoter and showed that viral oncogene expression significantly increased the susceptibility of animals to multi-stage skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) (Viarisio et al., 2011) . This classical model of chemically induced multi-step skin carcinogenesis enables three different stages of tumorigenesis to be differentiated: (i) initiation, induced by applying the strong carcinogen DMBA, which is responsible for inducing DNA mutations; (ii) promotion, associated with treatment with TPA, which causes sustained hyperplasia, inflammation and subsequently, selective clonal expansion; and (iii) progression (Abel et al., 2009; Rundhaug & Fischer, 2010) . The first two stages are associated with the development of benign lesions or papillomas, whereas progression relates to the malignant conversion of a benign lesion. The contribution of beta HPV E6 and E7 oncoproteins to these events in animal models is still poorly investigated. In this study, we determined the ability of HPV38 E6 and E7 to cooperate with either the initiator DMBA or the promoter TPA in the development of skin lesions.
We previously generated two Tg lines, 183 and 187, that express comparatively high (line 183) and low (line 187) levels of HPV38 E6 and E7 transcripts in the undifferentiated basal layer of epithelia and showed that expression of the viral oncogenes strongly enhanced tumour formation. Upon treatment of skin with both DMBA and TPA, Tg mice rapidly developed a large number of tumours and squamous cell carcinomas (SCCs), with significantly higher incidence than that found in wild-type control mice (Viarisio et al., 2011) . To further investigate the role of beta HPV38 oncoproteins in multi-stage skin carcinogenesis in mice, in this study, we evaluated their ability to cooperate with either DMBA or TPA to induce skin lesions. The time to the first lesion was recorded and displayed with a Kaplan-Meier plot. This was then compared between the different groups using the log-rank test. A P-value ,0.05 was considered to be statistically significant. All experiments described in this study were performed in strict accordance with federal law and the standard ethical guidelines (NIH, The Health Research Extension Act of 1985; European Communities Directives of 1986, 86/609/ EEC) and were approved by local government authorities (Regierungspräsidium Karlsruhe, Germany).
Since studies on different HPV types suggested that the majority of early gene products are expressed at relatively low levels, we decided to perform the experiments with the Tg line that expressed the lowest levels of viral genes, line 187. First, we determined whether HPV38 E6 and E7 oncoproteins could initiate the carcinogenic process by treating Tg line 187 (n58) and wild-type FVB/N (n58) animals with TPA alone for 20 weeks, following the protocol shown in Fig. 1(a) . For epicutaneous application of the promoter, the dorsal skin of 6-week-old female mice was shaved with electric clippers 7 days before starting the treatment. Then, 100 ml 50 mM TPA in acetone was applied twice a week on the dorsal skin. In a previous study, we demonstrated that the application of the solvent alone had no effect on wild-type or Tg animals (Viarisio et al., 2011) . Upon TPA treatment, no skin lesions were observed in the FVB/N control group treated for 20 weeks, whereas two Tg animals each developed a small papilloma around week 17 (Fig. 1b, c) . However, the difference in tumour incidence between the control and Tg animal cohorts was not statistically significant (P-value50.312). Histological analyses confirmed that the wild-type animals had normal skin morphology with unaffected hair follicles and sebaceous glands (Fig. 1d) . One Tg mouse showed an advanced lesion with papillomatosis, hyperkeratosis and acanthosis. A marked proliferation was evident at the basal layer, whereas hypergranulosis and vacuolated cells were observed in the upper layer. In the second Tg animal, we observed a sharply defined small lesion with outgrowths (or exophytic proliferations) of the epidermis and hyperkeratosis with no sign of dysplasia (Fig. 1d) . Together, these data show that the two viral oncoproteins do not play a significant role in the initial stage of multi-step skin carcinogenesis.
Next, we determined whether HPV38 E6 and E7 oncoproteins could promote tumour formation after the initiation of skin carcinogenesis with a subcarcinogenic dose of DMBA. Wild-type (n58) and Tg line 187 (n58) animals were exposed only once to DMBA (200 ml 2 mM DMBA in acetone was applied to the shaved back of 7-week-old female mice) and the animals were monitored weekly for 30 weeks (Fig. 2a) . Most of the Tg animals (75 %) rapidly developed skin lesions, 50 % of which were then classified as invasive squamous carcinomas, whereas no skin abnormalities were observed in the control mice during the 30 weeks of follow-up (Fig. 2b, c) . The difference in tumour incidence between the control and Tg animal cohorts was statistically significant (P-value ,0.05). Sections of two representative lesions are shown in Fig. 2(d) .
One lesion was diagnosed to be an SCC with infiltrating islands of atypical keratinocytes. The analysis also revealed the presence of large horn pearls with aggregates of keratinocytes in concentric arrangements, with varying degrees of keratinization at their centres. In the second specimen, we observed endophytic proliferation of the epidermis with hyperkeratosis and accumulation of horn columns and pearls with a deep and irregular proliferation pattern (Fig. 2d) . Thus, HPV38 E6 and E7 oncoproteins cooperate with DMBA, acting at the stages of promotion and progression.
In the multi-stage chemical skin carcinogenesis approach, DMBA acts as an initiator, inducing irreversible DNA damage, e.g. mutation of the oncogene Ha-ras at codon 61 (Fujiki et al., 1989) . The promotion and progression stages in carcinogenesis are mediated by the loss of control of several fundamental cellular events, such as proliferation, signalling pathways, differentiation and apoptosis (Rundhaug & Fischer, 2010) . These cellular alterations significantly facilitate the clonal expansion of cells harbouring DNA damage induced by the initiator (e.g. DMBA), which in turn determines the development of skin cancers. In this study, we have observed that HPV38 E6 and E7 oncoproteins can play the role of the tumour promoter TPA in two-stage skin carcinogenesis. These results are consistent with findings obtained in in vitro models, in which HPV38 E6 and E7 had the ability to interfere with the regulation of cell signalling, proliferation and apoptosis (Accardi et al., 2006 (Accardi et al., , 2011 Caldeira et al., 2003; Muschik et al., 2011; Underbrink et al., 2008) .
We previously showed that K14 HPV38 E6/E7 Tg animals, when exposed to chronic UV irradiation, developed SCCs (Viarisio et al., 2011) . In contrast, wild-type animals exposed to the same doses of UV irradiation did not show any type of skin lesion. Thus, HPV38 E6 and E7 strongly cooperate with UV in skin carcinogenesis. Since DMBA and UV share the ability to act as initiators, inducing DNA damage, the increased susceptibility of K14 HPV38 E6/E7 Tg mice to UV-induced carcinogenesis may be explained by the ability of the viral oncoproteins to act as promoter and progression factors. In conclusion, these findings provide additional insights into the role of beta HPV types in skin carcinogenesis. In vivo transforming properties of beta HPV38 E6 and E7
